Skip to main content
Clinical Trials/RBR-9gm9bz
RBR-9gm9bz
Recruiting
Phase 3

Determining factors of prognosis and morbidity in Chronic Chagas Heart Disease - phase III - DCHD: Dilated Chagasic Heart Disease

niversidade Federal de Minas Gerais0 sitesJune 12, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Federal de Minas Gerais
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 12, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de Minas Gerais

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Chagas disease by at least two of the three positive serological tests for Trypanosoma cruzi (indirect immunofluorescence, indirect hemoglutination and ELISA). Present a stable clinical condition, defined as no acute exacerbation of heart disease in the last three months. Presence of cardiac involvement defined, on echocardiogram, by the presence of left ventricular dysfunction (ejection fraction lower 52% for males and 54% for females). Presence of clinical signs and symptoms of heart failure (NYHA II and III). Not being a smoker and denying routine exposure to smoking
  • Presence of inspiratory muscle weakness defined with maximum inspiratory pressure values lower 70% of predicted. Be aged between 30 and 60 years. Be sedentary according to the International Physical Activity Questionnaire (IPAQ). Not having previous episodes of stroke and not having pulmonary, renal pathologies, musculoskeletal limitations and diabetes mellitus, conditions that alter the ability to perform functional tests.

Exclusion Criteria

  • Warm\-up activities before carrying out stress tests as well as any other contraindications to the maximum and submaximal tests.
  • Failure to perform the study's evaluation procedures. Only for the experimental group: do not perform inspiratory muscle training for two days in the same week (at home) or are absent from two supervised sessions during training.

Outcomes

Primary Outcomes

Not specified

Similar Trials